Cencora, Inc.

COR Healthcare Medical Distribution

Cencora, Inc.’s revenue for fiscal 2026 (year ended September 2026) was $337.4 billion, up 5.00% from fiscal 2025.

Revenue
+5.52%
EPS
+258.4%
Free cash flow
−7.81%
Total debt
+47.1%

Quarter to September 2026, against a year earlier

335.33 4.35 −1.28%
Market cap
$64.8B
P/E
18.8×
Fwd P/E
17.5×
Dividend yield
0.71%
F-score
7/9
Altman Z
n/a
Beneish M
−2.59
Dividend safety
70/100
Older periods Dec '25 Mar '26 Jun '26 Sep '26
P/E ratio

+8 more quarters

40.30 23.94 20.93 16.64
P/S ratio
0.20 0.19 0.16 0.17
P/FCF ratio
17.97 38.15 13.31 14.76
P/Operating CF
(28.46) 45.65 20.59 18.47
P/B ratio
31.30 17.05 16.87 17.69
EV/Sales
0.22 0.22 0.19 0.19
EV/EBITDA
19.22 18.58 15.46 15.49
EV/FCF
19.66 44.52 15.48 16.41
Current Ratio
0.92 0.95 0.93 0.94
Net Debt/EBITDA
6.02 7.26 6.37 0.00
Debt/Equity
3.78 3.45 3.62 3.06
Earnings Yield
2.48% 4.18% 4.78% 6.01%
Free Cash Flow Yield
5.56% 2.62% 7.51% 6.77%
Free Cash Flow per Share
(12.26) 6.03 12.58 13.93
Book value per Share
10.79 18.43 16.77 19.29
Free Cash Flow
(2,381.49) 1,173.74 2,430.06 2,658.35
EV/EBIT
26.75 25.57 20.90 16.20
Other line items

Show all line items

Columns are period end dates · fundamentals updated 5 Nov 2026